---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033762"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:51:43.596300+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# bioAffinity Technologies CFO resigns; J. Michael Edwards named interim CFO

## Summary
- CFO Michael Dougherty resigns effective Sept. 16, 2024; no disagreement with company.
- J. Michael Edwards appointed interim CFO effective Sept. 16, 2024; served as CFO from 2014 to 2023 and led 2022 IPO.
- Edwards receives $10,000/month salary plus expenses under consulting agreement; company will search for permanent CFO.
- Dougherty will assist transition through Sept. 15, 2024; accepting CFO role in Pacific Northwest energy industry.

## SEC filing metadata
- accession: 0001493152-24-033762
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315224033762/0001493152-24-033762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315224033762/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033762
- JSON: https://secwatch.observer/filing/0001493152-24-033762.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033762.txt

## Key facts
- Executive change
  Michael Dougherty resigned as Chief Financial Officer and Principal Accounting Officer at bioAffinity Technologies, Inc..
  - Action: resigned
  - Role: Chief Financial Officer and Principal Accounting Officer
  source text: Michael Dougherty notified bioAffinity Technologies, Inc. (the "Company") of his decision to resign from his position as the Company’s Chief Financial Officer and Principal Accounting Officer to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1712762/000149315224033762/0001493152-24-033762-index.htm
- Executive change
  Michael Edwards was appointed as Interim Chief Financial Officer and Principal Accounting Officer at bioAffinity Technologies, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer and Principal Accounting Officer
  source text: the Board of Directors of the Company appointed, effective as of September 16, 2024, Michael Edwards, age 57, to serve as the Company’s Interim Chief Financial Officer and Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1712762/000149315224033762/0001493152-24-033762-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.